The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 31, 2021

Filed:

Jan. 12, 2021
Applicant:

Infirst Healthcare Limited, London, GB;

Inventors:

Robin Mark Bannister, Essex, GB;

John Brew, Hertfordshire, GB;

Wilson Caparros-Wanderley, Buckinghamshire, GB;

Gregory Alan Stoloff, London, GB;

Suzanne Jane Dilly, Oxfordshire, GB;

Gemma Szucs, Oxfordshire, GB;

Olga Pleguezuelos Mateo, Bicester, GB;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/192 (2006.01); A61K 9/08 (2006.01); A61K 47/44 (2017.01); A61K 9/20 (2006.01); A61K 31/60 (2006.01); A61K 47/10 (2017.01); A61K 47/14 (2017.01); A61K 47/34 (2017.01); A61K 31/196 (2006.01); A61K 31/215 (2006.01); A61K 31/22 (2006.01); A61K 31/40 (2006.01); A61K 31/216 (2006.01); A61K 31/19 (2006.01);
U.S. Cl.
CPC ...
A61K 31/192 (2013.01); A61K 9/08 (2013.01); A61K 9/2013 (2013.01); A61K 31/196 (2013.01); A61K 31/60 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/34 (2013.01); A61K 47/44 (2013.01); A61K 31/19 (2013.01); A61K 31/215 (2013.01); A61K 31/216 (2013.01); A61K 31/22 (2013.01); A61K 31/40 (2013.01); Y02A 50/30 (2018.01);
Abstract

The present specification discloses pharmaceutical compositions formulated as a suspension for oral administration, the suspension comprising solid particles of a non-steroidal anti-inflammatory drug (NSAID) in an oil carrier comprising one or more free fatty acids, a glycerolipid, and a phospholipid as well as methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.


Find Patent Forward Citations

Loading…